Table 2 Number of IGF mRNA positive lung cancer tissues
From: Insulin-Like Growth Factor Family and Combined Antisense Approach in Therapy of Lung Carcinoma
+IGF-IR | +IGFBP-4 | +IGF-IR +IGFBP-4 | +IGF-IR + IGFBP-4 +IGF-II | ||
|---|---|---|---|---|---|
IGF-I | 32 | 23 | 17 | 17 | 17 |
46.4% | 33.3% | 24.6% | 24.6% | 24.6% | |
IGF-II | 39 | 39 | 34 | 34 | — |
56.5% | 56.5% | 49.2% | 49.2% | ||
IGF-IR | 48 | — | 35 | — | — |
69.6% | 50.7% | ||||
IGFBP-4 | 35 | 35 | — | — | — |
50.7% | 50.7% | ||||
None IGF | 12 | — | — | — | — |
17.4% | |||||
Total | 69 | — | — | — | — |
100% |